| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Molecular Biology, Pathobiology, and Genetics |
Departments of 1 Medicine and 2 Pathology, Memorial Sloan-Kettering Cancer Center; 3 The Rockefeller University, New York, New York; and 4 Department of Oncology and the Lombardi Comprehensive Cancer Center, Georgetown University, Washington, District of Columbia
Requests for reprints: Jacqueline Bromberg, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, New York, NY 10021. Phone: 212-639-8191; Fax: 646-422-2231; E-mail: bromberj{at}mskcc.org.
Signal transducers and activators of transcription 3 (STAT3) is a transcription factor that is aberrantly activated in many cancer cells. Constitutively activated STAT3 is oncogenic, presumably as a consequence of the genes that it differentially regulates. Activated STAT3 correlated with elevated cyclin D1 protein in primary breast tumors and breast cancer–derived cell lines. Cyclin D1 mRNA levels were increased in primary rat-, mouse-, and human-derived cell lines expressing either the oncogenic variant of STAT3 (STAT3-C) or vSrc, which constitutively phosphorylates STAT3. Mutagenesis of STAT3 binding sites within the cyclin D1 promoter and chromatin immunoprecipitation studies showed an association between STAT3 and the transcriptional regulation of the human cyclin D1 gene. Introduction of STAT3-C and vSrc into immortalized cyclin D1–/– and cyclin D1–/+ fibroblasts led to anchorage-independent growth of only cyclin D1–/+ cells. Furthermore, knockdown of cyclin D1 in breast carcinoma cells led to a reduction in anchorage-independent growth. Phosphorylation of the retinoblastoma (Rb) protein [a target of the cyclin D1/cyclin-dependent kinase 4/6 (cdk4/6) holoenzyme] was delayed in the cyclin D1–/– cells relative to cyclin D1–/+ cells. The E7 oncogene, whose activity includes degradation of Rb and dissociation of Rb from E2F, did not confer anchorage-independent growth to the cyclin D1–/– cells but, in conjunction with vSrc, resulted in robust growth in soft agar. These results suggest both a cdk-dependent and cdk-independent role for cyclin D1 in modulating transformation by different oncogenes. (Cancer Res 2006; 66(5): 2544-52)
This article has been cited by other articles:
|
|
 |
|
  Z. Syed, S. B. Cheepala, J. N. Gill, J. Stein, C. A. Nathan, J. DiGiovanni, V. Batra, P. Adegboyega, H. E. Kleiner, and J. L. Clifford All-Trans Retinoic Acid Suppresses Stat3 Signaling during Skin Carcinogenesis Cancer Prevention Research, October 1, 2009; 2(10): 903 - 911. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. B. Ernst, C. M. Wunderlich, S. Hess, M. Paehler, A. Mesaros, S. B. Koralov, A. Kleinridders, A. Husch, H. Munzberg, B. Hampel, et al. Enhanced Stat3 Activation in POMC Neurons Provokes Negative Feedback Inhibition of Leptin and InsulinSignaling in Obesity J. Neurosci., September 16, 2009; 29(37): 11582 - 11593. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 V. N. Ivanov, H. Zhou, M. A. Partridge, and T. K. Hei Inhibition of Ataxia Telangiectasia Mutated Kinase Activity Enhances TRAIL-Mediated Apoptosis in Human Melanoma Cells Cancer Res., April 15, 2009; 69(8): 3510 - 3519. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Z. Yagil, G. Kay, H. Nechushtan, and E. Razin A Specific Epitope of Protein Inhibitor of Activated STAT3 Is Responsible for the Induction of Apoptosis in Rat Transformed Mast Cells J. Immunol., February 15, 2009; 182(4): 2168 - 2175. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. A. Klein and R. K. Assoian Transcriptional regulation of the cyclin D1 gene at a glance J. Cell Sci., December 1, 2008; 121(23): 3853 - 3857. [Full Text] [PDF]
|
|
|
|
 |
|
 U. Dougherty, A. Sehdev, S. Cerda, R. Mustafi, N. Little, W. Yuan, S. Jagadeeswaran, A. Chumsangsri, J. Delgado, M. Tretiakova, et al. Epidermal Growth Factor Receptor Controls Flat Dysplastic Aberrant Crypt Foci Development and Colon Cancer Progression in the Rat Azoxymethane Model Clin. Cancer Res., April 15, 2008; 14(8): 2253 - 2262. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Vigneron, E. Gamelin, and O. Coqueret The EGFR-STAT3 Oncogenic Pathway Up-regulates the Eme1 Endonuclease to Reduce DNA Damage after Topoisomerase I Inhibition Cancer Res., February 1, 2008; 68(3): 815 - 825. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Ishii, S. Waxman, and D. Germain Tamoxifen Stimulates the Growth of Cyclin D1-Overexpressing Breast Cancer Cells by Promoting the Activation of Signal Transducer and Activator of Transcription 3 Cancer Res., February 1, 2008; 68(3): 852 - 860. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Germain and D. A. Frank Targeting the Cytoplasmic and Nuclear Functions of Signal Transducers and Activators of Transcription 3 for Cancer Therapy Clin. Cancer Res., October 1, 2007; 13(19): 5665 - 5669. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M.-C. Maa, J.-C. Lee, Y.-J. Chen, Y.-J. Chen, Y.-C. Lee, S.-T. Wang, C.-C. Huang, N.-H. Chow, and T.-H. Leu EPS8 Facilitates Cellular Growth and Motility of Colon Cancer Cells by Increasing the Expression and Activity of Focal Adhesion Kinase J. Biol. Chem., July 6, 2007; 282(27): 19399 - 19409. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. M. Silva and M. A. Shupnik Integration of Steroid and Growth Factor Pathways in Breast Cancer: Focus on Signal Transducers and Activators of Transcription and Their Potential Role in Resistance Mol. Endocrinol., July 1, 2007; 21(7): 1499 - 1512. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. K. Jung, P. Arora, J. S. Pagano, and K. L. Jang Expression of DNA Methyltransferase 1 Is Activated by Hepatitis B Virus X Protein via a Regulatory Circuit Involving the p16INK4a-Cyclin D1-CDK 4/6-pRb-E2F1 Pathway Cancer Res., June 15, 2007; 67(12): 5771 - 5778. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Azare, K. Leslie, H. Al-Ahmadie, W. Gerald, P. H. Weinreb, S. M. Violette, and J. Bromberg Constitutively Activated Stat3 Induces Tumorigenesis and Enhances Cell Motility of Prostate Epithelial Cells through Integrin {beta}6 Mol. Cell. Biol., June 15, 2007; 27(12): 4444 - 4453. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. K. Saxena, P. M. Vertino, F. A. Anania, and D. Sharma Leptin-induced Growth Stimulation of Breast Cancer Cells Involves Recruitment of Histone Acetyltransferases and Mediator Complex to CYCLIN D1 Promoter via Activation of Stat3 J. Biol. Chem., May 4, 2007; 282(18): 13316 - 13325. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
O. Dalmizrak, A. Wu, J. Chen, H. Sun, F. E. Utama, D. Zambelli, T. H. Tran, H. Rui, and R. Baserga Insulin Receptor Substrate-1 Regulates the Transformed Phenotype of BT-20 Human Mammary Cancer Cells Cancer Res., March 1, 2007; 67(5): 2124 - 2130. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. M. Williams, F. Sotgia, H. Lee, G. Hassan, D. Di Vizio, G. Bonuccelli, F. Capozza, I. Mercier, H. Rui, R. G. Pestell, et al. Stromal and Epithelial Caveolin-1 Both Confer a Protective Effect Against Mammary Hyperplasia and Tumorigenesis: Caveolin-1 Antagonizes Cyclin D1 Function in Mammary Epithelial Cells Am. J. Pathol., November 1, 2006; 169(5): 1784 - 1801. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Ishii, A. Pirkmaier, J. V. Alvarez, D. A. Frank, I. Keselman, D. Logothetis, J. Mandeli, M. J. O'Connell, S. Waxman, and D. Germain Cyclin d1 overexpression and response to bortezomib treatment in a breast cancer model. J Natl Cancer Inst, September 6, 2006; 98(17): 1238 - 1247. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |
